Botulinum Toxin A Improves the Quality of Life of Patients with Neurogenic Urinary Incontinence
- 30 September 2007
- journal article
- research article
- Published by Elsevier BV in European Urology
- Vol. 52 (3), 850-859
- https://doi.org/10.1016/j.eururo.2007.04.026
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Improving the global management of the neurogenic bladder patient: part I. The complexity of patientsCurrent Medical Research and Opinion, 2005
- BOTULINUM TOXIN TYPE A IS A SAFE AND EFFECTIVE TREATMENT FOR NEUROGENIC URINARY INCONTINENCE: RESULTS OF A SINGLE TREATMENT, RANDOMIZED, PLACEBO CONTROLLED 6-MONTH STUDYJournal of Urology, 2005
- Success of Repeat Detrusor Injections of Botulinum A Toxin in Patients with Severe Neurogenic Detrusor Overactivity and IncontinenceEuropean Urology, 2004
- Bladder and sexual function among women with multiple sclerosisMultiple Sclerosis Journal, 2004
- Symptom severity and QOL scales for urinary incontinenceGastroenterology, 2004
- Botulinum Toxin A for Treatment of Neurogenic Detrusor Overactivity and Incontinence in Patients with Spinal Cord LesionsScandinavian Journal of Urology and Nephrology, 2004
- Impact of Urinary Incontinence and Overactive Bladder on Quality of LifeEuropean Urology, 2003
- Bladder Management and Quality of Life After Spinal Cord InjuryAmerican Journal of Physical Medicine & Rehabilitation, 2001
- A health related quality of life measure for use in patients with urge urinary incontinence: A validation studyQuality of Life Research, 1999
- Quality of life of persons with urinary incontinence: Development of a new measureUrology, 1996